Tepylute 15 mg/1.5 mL (10 mg/mL) injection Images
Generic Name: thiotepa
This medication has been identified as Tepylute 15 mg/1.5 mL (10 mg/mL) injection. It is supplied by Shorla Oncology.
Tepylute is used in the treatment of Breast Cancer; Ovarian Cancer and belongs to the drug class alkylating agents. There is positive evidence of human fetal risk during pregnancy. Tepylute 15 mg/1.5 mL (10 mg/mL) injection is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Tepylute
- Generic Name
- thiotepa
- Strength
- 15 mg/1.5 mL (10 mg/mL) injection
- Availability
- Prescription only
- Drug Class
- Alkylating agents
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Shorla Oncology
- National Drug Code (NDC)
- 81927-0105
More about Tepylute (thiotepa)
- Check interactions
- Compare alternatives
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: alkylating agents
- Breastfeeding
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.